BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23463422)

  • 1. No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.
    Ziai W; Moullaali T; Nekoovaght-Tak S; Ullman N; Brooks JS; Morgan TC; Hanley DF
    Neurocrit Care; 2013 Jun; 18(3):354-61. PubMed ID: 23463422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.
    Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; Narula R; Guo KH; Claassen J; Lee K; Badjatia N; Mayer SA; Connolly ES
    Neurosurgery; 2010 Apr; 66(4):648-55. PubMed ID: 20305489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular fibrinolysis does not increase perihemorrhagic edema after intracerebral hemorrhage.
    Volbers B; Wagner I; Willfarth W; Doerfler A; Schwab S; Staykov D
    Stroke; 2013 Feb; 44(2):362-6. PubMed ID: 23306318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.
    Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH
    Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Volumetric Change of Intracerebral Hemorrhage in Patients Treated with Thrombolysis for Intraventricular Hemorrhage.
    Staub-Bartelt F; van Lieshout JH; Beez T; Kram R; Hänggi D; Beseoglu K
    Neurocrit Care; 2021 Apr; 34(2):529-536. PubMed ID: 32737761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage.
    Witsch J; Roh DJ; Avadhani R; Merkler AE; Kamel H; Awad I; Hanley DF; Ziai WC; Murthy SB
    JAMA Netw Open; 2021 Dec; 4(12):e2135773. PubMed ID: 34860246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of intraventricular hemorrhage (IVH) thrombolysis based on CT localization of external ventricular drain (EVD) fenestrations and analysis of EVD tract hemorrhage.
    Jackson DA; Patel AV; Darracott RM; Hanel RA; Freeman WD; Hanley DF
    Neurocrit Care; 2013 Aug; 19(1):103-10. PubMed ID: 22544476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous Intraventricular Hemorrhage: When Should Intraventricular tPA Be Considered?
    Abdelmalik PA; Ziai WC
    Semin Respir Crit Care Med; 2017 Dec; 38(6):745-759. PubMed ID: 29262432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.
    Newell DW; Shah MM; Wilcox R; Hansmann DR; Melnychuk E; Muschelli J; Hanley DF
    J Neurosurg; 2011 Sep; 115(3):592-601. PubMed ID: 21663412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A randomized trial and individual patient data meta-analysis.
    Staykov D; Kuramatsu JB; Bardutzky J; Volbers B; Gerner ST; Kloska SP; Doerfler A; Schwab S; Huttner HB
    Ann Neurol; 2017 Jan; 81(1):93-103. PubMed ID: 27888608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator.
    Mayfrank L; Kim Y; Kissler J; Delsing P; Gilsbach JM; Schröder JM; Weis J
    Acta Neuropathol; 2000 Nov; 100(5):561-7. PubMed ID: 11045679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase, a promising candidate for fibrinolytic therapy for intracerebral hemorrhage.
    Tan Q; Chen Q; Niu Y; Feng Z; Li L; Tao Y; Tang J; Yang L; Guo J; Feng H; Zhu G; Chen Z
    J Neurosurg; 2017 Feb; 126(2):548-557. PubMed ID: 27104852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the Ommaya Reservoir in Managing Ventricular Hemorrhage.
    Yang XT; Feng DF; Zhao L; Sun ZL; Zhao G
    World Neurosurg; 2016 May; 89():93-100. PubMed ID: 26724628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment.
    Mayfrank L; Kissler J; Raoofi R; Delsing P; Weis J; Küker W; Gilsbach JM
    Stroke; 1997 Jan; 28(1):141-8. PubMed ID: 8996503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages.
    Thiex R; Weis J; Krings T; Barreiro S; Yakisikli-Alemi F; Gilsbach JM; Rohde V
    J Neurosurg; 2007 Feb; 106(2):314-20. PubMed ID: 17410717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting clot lysis rates in patients with spontaneous intraventricular hemorrhage.
    Ziai WC; Muschelli J; Thompson CB; Keyl PM; Lane K; Shao S; Hanley DF
    Stroke; 2012 May; 43(5):1234-9. PubMed ID: 22382155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraclot recombinant tissue-type plasminogen activator reduces perihematomal edema and mortality in patients with spontaneous intracerebral hemorrhage.
    Lian LF; Xu F; Tang ZP; Xue Z; Liang QM; Hu Q; Zhu WH; Kang HC; Liu XY; Wang FR; Zhu SQ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):165-171. PubMed ID: 24710926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III).
    Ziai WC; Tuhrim S; Lane K; McBee N; Lees K; Dawson J; Butcher K; Vespa P; Wright DW; Keyl PM; Mendelow AD; Kase C; Wijman C; Lapointe M; John S; Thompson R; Thompson C; Mayo S; Reilly P; Janis S; Awad I; Hanley DF;
    Int J Stroke; 2014 Jun; 9(4):536-42. PubMed ID: 24033910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.
    Kramer AH; Roberts DJ; Holodinsky J; Todd S; Hill MD; Zygun DA; Faris P; Wong JH
    Neurocrit Care; 2014 Oct; 21(2):275-84. PubMed ID: 24627207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Quantification of Hematoma Hounsfield Units on Noncontrast CT in Acute Intraventricular Hemorrhage Predicts Ventricular Clearance after Intraventricular Thrombolysis.
    Kornbluth J; Nekoovaght-Tak S; Ullman N; Carhuapoma JR; Hanley DF; Ziai W
    AJNR Am J Neuroradiol; 2015 Sep; 36(9):1609-15. PubMed ID: 26228884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.